iShares Biotechnology ETF (NASDAQ:IBB) Holdings Lifted by Blue Trust Inc.

Blue Trust Inc. boosted its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 22.5% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,088 shares of the financial services provider’s stock after buying an additional 200 shares during the quarter. Blue Trust Inc.’s holdings in iShares Biotechnology ETF were worth $144,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of IBB. BNP Paribas Financial Markets boosted its stake in iShares Biotechnology ETF by 29.3% during the third quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock valued at $346,561,000 after buying an additional 538,899 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund lifted its holdings in shares of iShares Biotechnology ETF by 32.9% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock valued at $96,533,000 after purchasing an additional 164,000 shares during the last quarter. Aprio Wealth Management LLC purchased a new stake in shares of iShares Biotechnology ETF during the fourth quarter valued at $18,476,000. DRW Securities LLC purchased a new stake in shares of iShares Biotechnology ETF during the third quarter valued at $5,990,000. Finally, Erste Asset Management GmbH purchased a new stake in shares of iShares Biotechnology ETF during the third quarter valued at $5,678,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Up 0.5 %

Shares of NASDAQ IBB opened at $139.43 on Friday. iShares Biotechnology ETF has a 12 month low of $123.60 and a 12 month high of $150.57. The business has a fifty day simple moving average of $135.56 and a 200-day simple moving average of $140.78.

iShares Biotechnology ETF Cuts Dividend

The business also recently announced a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were issued a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.